Navigation Links
GlaxoSmithKline 14th Annual IMPACT Awards Seek Greater Philadelphia and Camden Healthcare Nonprofits
Date:2/15/2010

care for the chronically ill, services for children with genetic disorders and comprehensive treatment for women with addiction.

To qualify for a GlaxoSmithKline IMPACT award, applicants must provide access to healthcare services (primary mission); have annual total operating expenses between $160,000 and $3 million, as documented in the organization's most recent fiscal year financial statement; and have been in existence as a 501(c)(3) nonprofit organization for at least five years. A panel of local and national healthcare delivery experts and GlaxoSmithKline representatives will determine the winners based on a strong demonstration of ongoing success in providing access to healthcare; commitment to serving people in need; facilitation of healthcare delivery, substantive partnerships; policy development; and a solid record of achievement, management and leadership.

The GlaxoSmithKline IMPACT Awards will be presented at an awards ceremony in Philadelphia in late 2010. For more details and to apply, please visit the GlaxoSmithKline site at www.gsk-us.com and select "Our work with communities," then click "Health programs," then click "Awards," and finally click "Philadelphia region" or call GlaxoSmithKline Community Partnerships at 215-751-5171.

About GlaxoSmithKline: GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline on the World Wide Web at

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
8. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
9. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
10. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
11. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 ALPINION MEDICAL SYSTEMS Co., Ltd., announced ... system. Developed to enhance user experience and patient care ... EX produces superb image quality. With advanced imaging technologies, ... general imaging, and shared service applications. Confidence ... renowned E-CUBE Series, the E-CUBE 15 EX provides advanced ...
(Date:7/2/2015)... Wilson Therapeutics AB , a privately-held biopharmaceutical company, today ... of directors. The appointment was approved by the shareholders ... "We are delighted to welcome Hans to Wilson,s ... of Wilson Therapeutics. "Hans brings significant global biopharmaceutical industry ... contributions to the Company." Hans Schikan is ...
(Date:7/1/2015)... , July 1, 2015   Cochlear Limited ... hearing solutions, announced today the US Food and ... Profile™ Implant with Slim Straight Electrode (CI522). Built ... in close collaboration with the world,s leading surgeons, ... platform designed to provide the most discreet appearance ...
Breaking Medicine Technology:E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3
... Pa., June 17, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... subsidiary VGX Animal Health, Inc., a developer of DNA-based ... achieved strong T cell responses from VAH-5000D, its DNA ... of dogs with cancer. This preclinical data was presented ...
... HeartWare International, Inc. (NASDAQ: HTWR - ... circulatory support technologies that are revolutionizing the treatment of ... is scheduled to make an investor presentation at the ... Time on Wednesday, June 22, 2011.  The conference is ...
Cached Medicine Technology:VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 2VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 3VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 4HeartWare to Present at the Wells Fargo 2011 Healthcare Conference 2
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... 02, 2015 , ... Get ready to hit the gym, ... the socks were first introduced, they have rapidly been gaining attention among active ... new, fun shades including: blue, lime, pink and red. , Utilizing innovative ...
(Date:7/2/2015)... ... July 02, 2015 , ... When ... met for the late June Web-based session, the speakers discussed the importance of ... managing high-risk patients through coordinated care. , During the session, participants learned the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Real Time Pain Relief (RTPR), makers of ... with Big Sky PBR to sponsor The Fifth Annual Big Sky Professional Bull ... will offer product samples of their popular pain relief lotion and products at the family ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital Anatomy, the industry ... their flagship product, 3D Tooth Atlas, version 7.6. This release delivers new and ... videos. This latest release of the 3D Tooth Atlas offers a much faster ...
Breaking Medicine News(10 mins):Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2
... application records informs research , , FREMONT, Calif., ... NCCC ) research reveals that children ... risk of the most common form of childhood leukemia. , , ... database unique to California to reveal an elevated risk in acute lymphoblastic ...
... , , MINNEAPOLIS, Sept. 24 ... cervical cancer screening program sponsored by the NorthPoint Heath & Wellness ... the Cure(R) - Minnesota Affiliate, will be held at the North ... 7, and 8. Appointments are being scheduled from 8:30 a.m. to ...
... , SAN FRANCISCO, Sept. 24 Volcano Corporation ... manufacturing and sales of products for the diagnosis and treatment ... from PROSPECT, the landmark 700 patient natural history study sponsored ... the progression of cardiovascular disease via precise, intravascular imaging, and ...
... , SALT LAKE CITY, Sept. 24 Dynatronics Corporation (Nasdaq: ... to its nationwide direct sales force, bringing the total to 50 - ... thrilled to be adding so many experienced representatives to our sales team," ... Dynatronics. "This is just one more way we,re benefiting from the ...
... EMERYVILLE, Calif., Sept. 24 Onyx Pharmaceuticals, Inc. ... webcast an investor briefing on Wednesday, September 30, 2009, beginning ... for Nexavar in breast cancer presented at the 15th European ... (ESMO) Multidisciplinary Congress in Berlin. , , ...
... C.S. Mott Children,s Hospital National Poll on Children,s Health ... against H1N1 flu, despite higher disease risk; Hispanic parents more likely to ... With schools back in session, H1N1 flu has become more active ... H1N1 flu -- strongly recommended for kids -- has been tested and ...
Cached Medicine News:Health News:Northern California Cancer Center Finds Increased Risk of Most Common Form of Childhood Leukemia Associated With Residential Proximity to Agricultural Pesticides 2Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 2Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 3Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 4Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 2Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 3Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 4Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 5Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 6Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 7Health News:Dynatronics Expands Nationwide Direct Sales Force by 25 Percent 2Health News:H1N1 Flu: Are Parents Underestimating Risk to Kids? 2Health News:H1N1 Flu: Are Parents Underestimating Risk to Kids? 3Health News:H1N1 Flu: Are Parents Underestimating Risk to Kids? 4
Torso Brief Bodysuit V-BA85...
A One Piece Support Garment - any length or size...
Body Suit w/Bra above knee...
Ideal for chest procedures....
Medicine Products: